Recall: D-0166-2027
Class II - Potentially Harmful
Class IIClassification
2026-10-20Initiated
OngoingStatus
Hikma Pharmaceuticals USA INC.Firm
Product
Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50
Reason
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Distribution
US Nationwide
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.